PROGRESS PHARMA
ActiveSummary
PROGRESS PHARMA has been active since 2013 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €47,137 and a net result of -€5,479. Equity is shrinking by about 15% per year across the filed financial years. Its solvency ranks better than 90% of 605 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Directors
Directors
under verification
This board is reconstructed from a single act (26002483). A Gazette act generally publishes only CHANGES, not a full roll call, so directors unchanged since then may be missing here. The KBO register holds the complete list of function holders.
Board 5
CONCORDE CONSULTING
CurrentDirector · Private limited company · permanent representative: Van Broekhoven Dirk Leo Esther Maria
Lammens Luc Marie Antoon Angèle
CurrentDirector
R&S Consulting
CurrentDirector · Private limited company · permanent representative: Reyn Dirk Maria Jozef
Salvegen Healthcare B.V.
CurrentDirector · Legal entity · permanent representative: van Dongen Emilius Hubertus Adrianus Maria
SIMBIOSIS.LIFE
CurrentDirector · Private limited company · permanent representative: Cools Marina, Marina Lucie Louise
Permanent representatives 4
Cools Marina, Marina Lucie Louise
CurrentPermanent representative · for SIMBIOSIS.LIFE
Reyn Dirk Maria Jozef
CurrentPermanent representative · for R&S Consulting
Van Broekhoven Dirk Leo Esther Maria
CurrentPermanent representative · for CONCORDE CONSULTING
van Dongen Emilius Hubertus Adrianus Maria
CurrentPermanent representative · for Salvegen Healthcare B.V.
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ.
See the directors and other office holders in the KBO →
Not every act has been read: a resignation may still be missing
5 of this company's 6 Belgian Official Gazette deeds have not been read yet. Appointments and resignations recorded in them are not yet in the list of directors: someone who resigned there may still be listed as sitting. The acts are in the Timeline.
Mandate history
5 people since 2026, 5 in office
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| CONCORDE CONSULTING |
|
| Lammens Luc Marie Antoon Angèle |
|
| R&S Consulting |
|
| Salvegen Healthcare B.V. |
|
| SIMBIOSIS.LIFE |
|
Owners and capital
Capital and shareholders
Capital over the years
- 06-01-2026 Capital reduction of €40,000 · to €460,000 · repaid to the shareholders
- 06-01-2026 Capital reduction of €398,500 · to €61,500 · “formele kapitaalvermindering zonder vernietiging van aandelen”